UNSPSC 51284903: Cilastatin/imipenem

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM119. This VA Drug Class (AM119) classifies this compound as belonging to the group BETA-LACTAMS ANTIMICROBIALS, OTHER.

UNSPSC 51284903 Cilastatin/imipenem is a Commodity code that encompasses pharmaceutical products including antibiotics and related injectable medications, though recent state and local solicitations tagged with this code show a pronounced mismatch with its nominal scope. The most recent opportunities under this code center on naloxone (an opioid antagonist), generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription program feasibility — none of which are cilastatin/imipenem specifically. State and local buyers using this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), cities (City of Tampa), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance). The work being solicited involves procurement of finished pharmaceutical products and medical consumables for distribution through authorized wholesalers, direct-to-manufacturer contracting arrangements, and emergency responder supply chains, with contract terms typically ranging from one to two years and including options for renewal or extension.

Geographic activity spans Florida (Seminole County), Texas, Minnesota and partnering states including Oregon, and Florida again with the City of Tampa. Representative recent solicitations include Seminole County's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's invitation to bid 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a Small Local Business Enterprise set-aside and 5 percent bid discount; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities; and the Texas Health and Human Services Commission's RFI HHS0017013 (response due April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription programs. The code shows limited alignment with its pharmaceutical taxonomy designation, suggesting either miscoding of recent opportunities or reduced activity in cilastatin/imipenem specifically.